Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buske

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Praxis|July 9, 1998
[Systemic therapy of low malignancy non-Hodgkin lymphomas]B Wörmann, C Buske, W Hiddemann
Cell Biology International|November 1, 1994
Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblastsC Buske, W Hiddemann, B Wörmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Advances in molecular biology diagnostic and treatment of B-cell malignancies: indolent B-cell lymphomaM Dreyling, C Buske, W Hiddemann
Der Internist|January 15, 2003
[Pathogenesis and biology of leukemias]M Feuring-Buske, W Hiddemann, C Buske
Der Internist|April 1, 2006
[Stem cell therapy. Biology of hematopoietic stem cells]C Buske, H Glimm, M Feuring-Buske
Cell Cycle (Georgetown, Tex.)|November 19, 2005
AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemiaF Kuchenbauer, M Feuring-Buske, C Buske
Journal of Internal Medicine. Supplement|January 1, 1997
Treatment of follicular follicle centre lymphomas: current status and future perspectivesW Hiddemann, M Unterhalt, C Buske, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2006
[Diagnostics and therapy of acute myeloid leukemia]S Fritsch, K Metzeler, W Hiddemann, et al.
Der Internist|November 2, 2004
[Monoclonal antibody treatment of malignant lymphoma]C Buske, M Dreyling, M Unterhalt, et al.
Deutsche Medizinische Wochenschrift (1946)|June 24, 2006
[Acute myeloid leukemia -- on the way towards pathogenesis-oriented treatment]K Metzeler, S Fritsch, C Buske, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Praxis|July 9, 1998
[Systemic therapy of low malignancy non-Hodgkin lymphomas]B Wörmann, C Buske, W Hiddemann
Cell Biology International|November 1, 1994
Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblastsC Buske, W Hiddemann, B Wörmann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2005
Advances in molecular biology diagnostic and treatment of B-cell malignancies: indolent B-cell lymphomaM Dreyling, C Buske, W Hiddemann
Der Internist|January 15, 2003
[Pathogenesis and biology of leukemias]M Feuring-Buske, W Hiddemann, C Buske
Der Internist|April 1, 2006
[Stem cell therapy. Biology of hematopoietic stem cells]C Buske, H Glimm, M Feuring-Buske
Cell Cycle (Georgetown, Tex.)|November 19, 2005
AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemiaF Kuchenbauer, M Feuring-Buske, C Buske
Journal of Internal Medicine. Supplement|January 1, 1997
Treatment of follicular follicle centre lymphomas: current status and future perspectivesW Hiddemann, M Unterhalt, C Buske, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2006
[Diagnostics and therapy of acute myeloid leukemia]S Fritsch, K Metzeler, W Hiddemann, et al.
Der Internist|November 2, 2004
[Monoclonal antibody treatment of malignant lymphoma]C Buske, M Dreyling, M Unterhalt, et al.
Deutsche Medizinische Wochenschrift (1946)|June 24, 2006
[Acute myeloid leukemia -- on the way towards pathogenesis-oriented treatment]K Metzeler, S Fritsch, C Buske, et al.
Pageof 10